NicVAX
id:
nicvax-199-10601024
title:
NicVAX
text:
NicVAX is an experimental conjugate vaccine intended to reduce or eliminate physical dependence to nicotine. According to the U.S. National Institute of Drug Abuse, NicVAX can potentially be used to inoculate against nicotine addiction. This proprietary vaccine is being developed by Nabi Biopharmaceuticals of Rockville, MD. with the support from the U.S. National Institute on Drug Abuse. NicVAX consists of the hapten 3'-aminomethylnicotine which has been conjugated (attached) to Pseudomonas aeru
brand slug:
wiki
category slug:
encyclopedia
description:
Experimental nicotine dependency vaccine
original url:
https://en.wikipedia.org/wiki/NicVAX
date created:
date modified:
2024-03-20T13:47:56Z
main entity:
{"identifier":"Q9049868","url":"https://www.wikidata.org/entity/Q9049868"}
image:
fields total:
13
integrity:
14